MicroCures Awarded $1.5M SBIR Grant To Support Development of Novel Therapeutic Platform for Accelerated Tissue Repair – Yahoo Finance
stemadminStem Cell MedicineNo comments

Funding to Support Ongoing Advancement of siFi2, Lead Candidate from Companys First-of-its-Kind Platform for Precisely Controlling Core Cell Migration Mechanisms NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- MicroCures, a biopharmaceutical company developing novel therapeutics that harness the bodys innate regenerative mechanisms to accelerate tissue repair, today announced that it has been awarded a Phase 2 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). The two-year, $1.5 million award will support ongoing development of the companys lead product candidate, siFi2.

Read more
Stem Cell And Regenerative Therapy Market 2019 New Innovations, Research and Growth Factor till 2024 – Pro News Time
stemadminStem Cell MedicineNo comments

The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-2024. Report Scope: The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries.

Read more
Dr Saw Khay Yong on founding KL Sports Medicine Centre and its revolutionary work in stem cell therapy – Options The Edge
stemadminStem Cell MedicineNo comments

Spectators exclaimed in horror at the 2018 MotoGP Asia Talent Cup race when Danial Syahmi Sharil almost lost his life in a serious accident. The 16-year-old rising star had a terrifying collision that saw him thrown off his motorcycle and then run over by a fellow racer on the Sepang International Circuit that November, suffering serious injuries in his lower left leg

Read more
The recombinant cell culture supplements market analysis by BIS Research projects the market to grow at a significant CAGR of 12.93% during the…
stemadminStem Cell MedicineNo comments

NEW YORK, Jan. 6, 2020 /PRNewswire/ -- Global Recombinant Cell Culture Supplements Market to Reach $977.8 Million by 2029 Read the full report: https://www.reportlinker.com/p05835676/?utm_source=PRN Key Questions Answered in this Report: What is the role of media and supplements in cell culture and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications?

Read more
Stem Cell Banking Market to Witness Exponential Growth by 2023 – Markets Gazette 24
stemadminStem Cell BankingNo comments

A new market research report on theGlobal Stem Cell Banking markethas introduced byKD Market Insights. The report is dedicated to in-depth industry analysis of the globalStem Cell Bankingmarket. TheGlobal Stem Cell Bankinganalysis is broken down on different segmentation levelsincluding MarketBy Cell Type, By Bank Type, By Service Type, By Utilization.

Read more
NIST researchers use artificial intelligence for quality control of stem cell-derived tissues – National Institutes of Health
stemadminStem Cell ResearchNo comments

News Release Thursday, November 14, 2019 Technique key to scale up manufacturing of therapies from induced pluripotent stem cells. Researchers used artificial intelligence (AI) to evaluate stem cell-derived patches of retinal pigment epithelium (RPE) tissue for implanting into the eyes of patients with age-related macular degeneration (AMD), a leading cause of blindness. The proof-of-principle study helps pave the way for AI-based quality control of therapeutic cells and tissues.

Read more
International Stem Cell Corporation Announces Financial Results for the Three and Nine-Months ended September 30, 2019 – Associated Press
stemadminStem Cell ResearchNo comments

Press release content from ACCESSWIRE. The AP news staff was not involved in its creation. Click to copy CARLSBAD, CA / ACCESSWIRE / November 15, 2019 / International Stem Cell Corporation (OTCQB:ISCO) ( http://www.internationalstemcell.com ) (ISCO or the Company), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today announced operating results for the three and nine months ended September 30, 2019.

Read more

Theme: Illdy.